Critical MHRA Alert: Pharmacists Advised of Error in Diflucan Patient Leaflets
The Medicines and Healthcare products Regulatory Agency (MHRA) has notified pharmacists of a typo in the patient leaflets for two batches of Diflucan Oral Suspension, wrongly indicating the concentration of fluconazole. Despite this, MHRA confirms the product quality remains unaffected. Pharmacists should remain vigilant but continue dispensing as usual.
Read More